Buy Dr. Reddy's Laboratories, target price Rs 4905: BNP Paribas

Dr. Reddy's Laboratories Ltd., incorporated in the year 1984, is a Large Cap company (having a market cap of Rs 72621.06 Crore) operating in Pharmaceuticals sector.

ETBFSI
Promoters held 26.72 per cent stake in the company as of 31-Dec-2021, while FIIs owned 27.42 per cent, DIIs 22.29 per cent.
BNP Paribas has buy call on Dr. Reddy's Laboratories Ltd. with a target price of Rs 4905. The current market price of Dr. Reddy's Laboratories is Rs 4361.9.

Dr. Reddy's Laboratories Ltd., incorporated in the year 1984, is a Large Cap company (having a market cap of Rs 72621.06 Crore) operating in Pharmaceuticals sector.

Dr. Reddy's Laboratories Ltd. key Products/Revenue Segments include Pharmaceuticals, Licence Fees, Other Operating Revenue, Spent Chemicals, Service Income and Scrap for the year ending 31-Mar-2022.



Financials
For the quarter ended 30-09-2022, the company reported a Consolidated Total Income of Rs 6372.60 Crore, up 4.70 % from last quarter Total Income of Rs 6086.80 Crore and up 6.34 % from last year same quarter Total Income of Rs 5992.40 Crore. Company reported net profit after tax of Rs 1100.20 Crore in latest quarter.


ADVERTISEMENT

Promoter/FII Holdings
Promoters held 26.71 per cent stake in the company as of 30-Sep-2022, while FIIs owned 25.87 per cent, DIIs 24.6 per cent.
ADVERTISEMENT
READ MORE

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Markets › Stocks › Recos › Buy Dr. Reddy's Laboratories, target price Rs 4905: BNP Paribas
Text Size:AAA
Success
This article has been saved

*

+